Comparison of Degradable Porous Scaffolds in the In Vivo Formation of Tissue-Engineered Bone Using Adipose Tissue-derived Stem Cells (ADSCs)
World Small Animal Veterinary Association World Congress Proceedings, 2007
Se-Il Park; Jae-Ho Jeong;Young-Mi Moon; San-Ok Kim; Jang-Yoon Choi; Kwang-Ho Jang*

Background

The ADSCs, have the capacity for renewal and the potential to differentiate into multiple lineages of mesenchymal tissues. These cells are capable of forming bone when implanted in an appropriate scaffold.

Aims

We evaluate the effect of reconstructing bone defect by using degradable porous scaffolds seeded with ADSCs and compare the suitability of different biomaterial porous scaffolds; Hydroxyapatite/beta-Tricalcium Phosphate, Beta-Tricalcium Phosphate, Calcium Meta phosphate , Collagen-coated CMP.

Methods

ADSCs were obtained 24 adult Beagles undergoing lipectomy. The cells were isolated, cultured, labeled and seeded in vitro. The experimental group received ADSCs scaffolds and the control group received the acellular scaffolds into femoral defects, respectively. The bone blocks were retrieved at 4, 8, 12 weeks after the surgery for radiographic, biochemistry, histomorphologic analysis.

Results

Histological analysis revealed that implants loaded with autologous ADSCs, had greater amounts of bone within the available pore space than the acellular implants, especially in Calcium Meta phosphate (CMP) group.(p < 0.05). Newly formed bone was observed in the healed defects at 12 weeks and the osteoblastic differentiation of implant with ADSCs was much more than that of the control.

Conclusion

The harvested ADSCs possess the ability to form new bone tissue when seeded onto CMP, which shows the potential of using this method to repair large bone defect clinically.

*Corresponding author

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Kwang-Ho Jang
Kyungpook National University
Republic of Korea


MAIN : Abstracts - Poster : Degradable Porous Scaffolds
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27